Tempest Therapeutics, Inc. Amortization of Debt Discount (Premium)
Tempest Therapeutics, Inc. (TPST) reported Amortization of Debt Discount (Premium) of $52.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2020-03-11
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2018-12-31 was $228.00K.
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2018-09-30 was -$76.00K, a 860.00% decline year-over-year.
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2018-06-30 was -$65.00K, a 201.56% decline year-over-year.
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2018-03-31 was -$35.00K, a 229.63% decline year-over-year.
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2018 was $52.00K, a 11.86% decline from fiscal 2017.
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2017 was $59.00K, a 91.05% decline from fiscal 2016.
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2016 was $659.00K, a 40.95% decline from fiscal 2015.
- Tempest Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2015 was $1.12M, a 28.13% increase from fiscal 2014.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 21 month | Amortization of Debt Discount (Premium) 24 month | Amortization of Debt Discount (Premium) 27 month | Amortization of Debt Discount (Premium) 30 month | Amortization of Debt Discount (Premium) 33 month | Amortization of Debt Discount (Premium) 36 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $152.00K derived: sum of 2 quarters · filed 2020-03-11 | $87.00K derived: sum of 3 quarters · filed 2020-03-11 | $52.00K 10-K · filed 2020-03-11 | ||||||
| 2018-09-30 | -$76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$141.00K derived: sum of 2 quarters · filed 2018-11-09 | -$176.00K 10-Q · filed 2018-11-09 | -$218.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2018-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$100.00K 10-Q · filed 2018-08-09 | -$142.00K derived: sum of 3 quarters · filed 2018-08-09 | -$132.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2018-03-31 | -$35.00K 10-Q · filed 2018-05-03 | -$77.00K derived: sum of 2 quarters · filed 2018-05-03 | -$67.00K derived: sum of 3 quarters · filed 2018-11-09 | -$3.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$32.00K derived: sum of 2 quarters · filed 2018-11-09 | $32.00K derived: sum of 3 quarters · filed 2018-11-09 | $59.00K 10-K · filed 2018-03-15 | ||||||
| 2017-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $74.00K derived: sum of 2 quarters · filed 2018-11-09 | $101.00K 10-Q · filed 2018-11-09 | $153.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $91.00K 10-Q · filed 2018-08-09 | $143.00K derived: sum of 3 quarters · filed 2018-08-09 | $252.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2017-03-31 | $27.00K 10-Q · filed 2018-05-03 | $79.00K derived: sum of 2 quarters · filed 2018-05-03 | $188.00K derived: sum of 3 quarters · filed 2018-05-03 | $391.00K derived: sum of 4 quarters · filed 2018-05-03 | ||||||
| 2016-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $161.00K derived: sum of 2 quarters · filed 2018-03-15 | $364.00K derived: sum of 3 quarters · filed 2018-03-15 | $659.00K 10-K · filed 2018-03-15 | ||||||
| 2016-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $312.00K derived: sum of 2 quarters · filed 2017-11-02 | $607.00K 10-Q · filed 2017-11-02 | $931.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2016-06-30 | $203.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $498.00K 10-Q · filed 2017-08-03 | $822.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.17M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2016-03-31 | $295.00K 10-Q · filed 2017-05-09 | $619.00K derived: sum of 2 quarters · filed 2018-03-15 | $971.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.24M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $676.00K derived: sum of 2 quarters · filed 2018-03-15 | $945.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.12M 10-K · filed 2018-03-15 | ||||||
| 2015-09-30 | $352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $621.00K derived: sum of 2 quarters · filed 2016-11-03 | $792.00K 10-Q · filed 2016-11-03 | $1.02M derived: sum of 4 quarters · filed 2017-03-02 | ||||||
| 2015-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $440.00K 10-Q · filed 2016-08-04 | $673.00K derived: sum of 3 quarters · filed 2017-03-02 | $926.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||||
| 2015-03-31 | $171.00K 10-Q · filed 2016-05-05 | $404.00K derived: sum of 2 quarters · filed 2017-03-02 | $657.00K derived: sum of 3 quarters · filed 2017-03-02 | $893.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||||
| 2014-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $486.00K derived: sum of 2 quarters · filed 2017-03-02 | $722.00K derived: sum of 3 quarters · filed 2017-03-02 | $871.00K 10-K · filed 2017-03-02 | ||||||
| 2014-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $489.00K derived: sum of 2 quarters · filed 2015-11-05 | $638.00K 10-Q · filed 2015-11-05 | $815.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||||
| 2014-06-30 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $385.00K 10-Q · filed 2015-08-10 | $562.00K derived: sum of 3 quarters · filed 2016-02-26 | $745.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||||
| 2014-03-31 | $149.00K 10-Q · filed 2015-05-11 | $326.00K derived: sum of 2 quarters · filed 2016-02-26 | $509.00K derived: sum of 3 quarters · filed 2016-02-26 | $627.00K derived: sum of 4 quarters · filed 2016-02-26 | $812.00K 10-Q · filed 2014-05-08 | |||||
| 2013-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $360.00K derived: sum of 2 quarters · filed 2016-02-26 | $478.00K derived: sum of 3 quarters · filed 2016-02-26 | $586.00K 10-K · filed 2016-02-26 | $663.00K 10-K · filed 2014-02-27 | |||||
| 2013-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $301.00K derived: sum of 2 quarters · filed 2014-11-10 | $409.00K 10-Q · filed 2014-11-10 | $486.00K 10-Q · filed 2013-11-13 | ||||||
| 2013-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $226.00K 10-Q · filed 2014-08-07 | $303.00K 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | $108.00K 10-Q · filed 2014-05-08 | $185.00K 10-Q · filed 2013-05-15 | ||||||||
| 2012-12-31 | $77.00K 10-K · filed 2015-03-16 | $77.00K 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |